Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Lisata Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q3 2025
- Shares held
- 715.1K
- −24.1K (−3.3%) vs. Q3 2025
- Total value
- $1.36M
- −$578.5K (−29.9%) vs. Q3 2025
- New holders
- 6
- 7 more added
- Sold out
- 2
- 6 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LSTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $3.70M |
| Q1 2026 | 34 | $7.06M |
| Q4 2025 | 25 | $1.36M |
| Q3 2025 | 21 | $1.93M |
| Q2 2025 | 20 | $2.26M |
| Q1 2025 | 22 | $1.84M |
| Q4 2024 | 21 | $2.33M |
| Q3 2024 | 20 | $2.30M |
| Q2 2024 | 22 | $2.61M |
| Q1 2024 | 21 | $2.30M |
| Q4 2023 | 22 | $2.03M |
| Q3 2023 | 21 | $1.46M |
| Q2 2023 | 22 | $2.51M |
| Q1 2023 | 21 | $2.08M |
| Q4 2022 | 24 | $1.83M |
| Q3 2022 | 22 | $2.17M |
| Q2 2022 | 36 | $5.00M |
| Q1 2022 | 34 | $6.13M |
| Q4 2021 | 36 | $7.33M |
| Q3 2021 | 34 | $9.41M |
| Q2 2021 | 29 | $10.1M |
| Q1 2021 | 33 | $12.9M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Lisata Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $2 | 0.00% | +1 | New |
| Fortitude Family Office, LLC | 1 | $2 | 0.00% | +1 | New |
| SBI Securities Co., Ltd. | 7 | $13 | 0.00% | −133−95.0% | Reduced |
| Cheviot Value Management, LLC | 3 | $14 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 75 | $140 | 0.00% | −133−63.9% | Reduced |
| Advisor Group Holdings, Inc. | 100 | $186 | 0.00% | +100 | New |
| GWM Advisors LLC | 107 | $199 | 0.00% | +107 | New |
| UBS Group AG | 871 | $1.62K | 0.00% | +871 | New |
| Connective Capital Management, LLC | 1,016 | $1.89K | 0.00% | 00.0% | Unchanged |
| Founders Capital Management | 1,667 | $3.10K | 0.00% | −333−16.7% | Reduced |
| Tower Research Capital LLC (TRC) | 2,552 | $4.75K | 0.00% | +881+52.7% | Added |
| International Assets Investment Management, LLC | 5,000 | $9.30K | 0.00% | +5,000 | New |
| Royal Bank of Canada | 5,913 | $11.0K | 0.00% | +10.0% | Added |
| HighTower Advisors, LLC | 10,042 | $18.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 10,268 | $19.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 10,418 | $19.4K | 0.00% | +10.0% | Added |
| Dimensional Fund Advisors LP | 14,253 | $26.5K | 0.00% | −6,694−32.0% | Reduced |
| State Street Corp | 14,348 | $26.7K | 0.00% | 00.0% | Unchanged |
| Cerity Partners LLC | 12,183 | $49.1K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 38,987 | $72.5K | 0.15% | +15,213+64.0% | Added |
| BlackRock, Inc. | 54,857 | $102.0K | 0.00% | −33−0.1% | Reduced |
| Geode Capital Management, LLC | 64,428 | $119.9K | 0.00% | +1,168+1.8% | Added |
| BML Capital Management, LLC | 73,348 | $136.4K | 0.12% | −36,493−33.2% | Reduced |
| Renaissance Technologies LLC | 123,715 | $230.1K | 0.00% | +7,093+6.1% | Added |
| Vanguard Group Inc | 270,909 | $503.9K | 0.00% | +395+0.1% | Added |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,111−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |